Raymond James & Associates’s MINDBODY, Inc. Class A Common Stock MB Stock Holding History

Raymond James & Associates’s Portfolio MB Stock Details MB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,384	Closed	-$232K	–	3767
2018 Q4	$232K	Sell	6,384 -6,464	-50%	-$197K	﹤0.01%	3024
2018 Q3	$522K	Sell	12,848 -6,321	-33%	-$247K	﹤0.01%	2677
2018 Q2	$740K	Buy	19,169 +7,400	+63%	+$291K	﹤0.01%	2405
2018 Q1	$458K	Buy	11,769 +3,686	+46%	+$132K	﹤0.01%	2616
2017 Q4	$246K	Sell	8,083 -1,000	-11%	-$30.8K	﹤0.01%	2941
2017 Q3	$235K	Buy	9,083 +815	+10%	+$20.2K	﹤0.01%	2944
2017 Q2	$225K	Buy	+8,268	New	+$227K	﹤0.01%	2917

Other funds holding MB

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Raymond James & Associates's MB Position: Q1 2019 in Review

Raymond James & Associates sold out of MINDBODY, Inc. Class A Common Stock (MB) in Q1 2019, closing a stake of 6,384 shares — an estimated $232K sold.

Raymond James & Associates first reported a position in MB in Q2 2017 and held it in 7 quarters. The position peaked at $740K in Q2 2018. 1 fund tracked by Wall St. Rank holds MB as of Q1 2019.

Raymond James & Associates reported no remaining MINDBODY, Inc. Class A Common Stock position as of Q1 2019 after selling out during the quarter.
Raymond James & Associates sold 6,384 MINDBODY, Inc. Class A Common Stock shares in Q1 2019, an estimated $232K.
Raymond James & Associates first reported a position in MINDBODY, Inc. Class A Common Stock in Q2 2017 and held it in 7 quarters.
Raymond James & Associates's MINDBODY, Inc. Class A Common Stock position peaked at $740K in Q2 2018.
1 fund tracked by Wall St. Rank held MINDBODY, Inc. Class A Common Stock as of Q1 2019.

Based on Raymond James & Associates's 13F filing for Q1 2019, filed 6 May 2019.